Details of the Drug

General Information of Drug (ID: DMRJ5DB)

• Drug Name: MCC-257
• Synonyms: 5-Acetamido-N-(cholestan-3alpha-yl)-3,5-dideoxy-2-O-methyl-alpha-D-glycero-D-galacto-2-nonulopyranosonic acid amide

Indication

Disease Entry	ICD 11	Status	REF
Cognitive impairment	6D71	Discontinued in Phase 2	[1]

• Drug Type: Small molecular drug
• Chemical Identifiers:
  Formula: C39H68N2O8
  Canonical SMILES: CC(C)CCCC(C)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)NC(=O)C5(CC(C(C(O5)C(C(CO)O)O)NC(=O)C)O)OC)C)C
  InChI: 1S/C39H68N2O8/c1-22(2)9-8-10-23(3)28-13-14-29-27-12-11-25-19-26(15-17-37(25,5)30(27)16-18-38(28,29)6)41-36(47)39(48-7)20-31(44)33(40-24(4)43)35(49-39)34(46)32(45)21-42/h22-23,25-35,42,44-46H,8-21H2,1-7H3,(H,40,43)(H,41,47)/t23-,25+,26-,27+,28-,29+,30+,31+,32-,33-,34-,35-,37+,38-,39-/m1/s1
  InChIKey: CHMRTBYTCBDIRG-JQZMMWJVSA-N
• Cross-matching ID:
  PubChem CID: 46174145
  CAS Number: 204200-47-5
  UNII: G2D52T65LR
  DrugBank ID: DB14932
  TTD ID: D0G0CX

References

• [1] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800015003)